Tags

Type your tag names separated by a space and hit enter

The Wuhan SARS-CoV-2-What's next for China.
J Med Virol. 2020 06; 92(6):546-547.JM

Authors+Show Affiliations

Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.Cepheid, Danaher Diagnostic Platform, Shanghai, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32115732

Citation

Lu, Hongzhou, et al. "The Wuhan SARS-CoV-2-What's Next for China." Journal of Medical Virology, vol. 92, no. 6, 2020, pp. 546-547.
Lu H, Stratton CW, Tang YW. The Wuhan SARS-CoV-2-What's next for China. J Med Virol. 2020;92(6):546-547.
Lu, H., Stratton, C. W., & Tang, Y. W. (2020). The Wuhan SARS-CoV-2-What's next for China. Journal of Medical Virology, 92(6), 546-547. https://doi.org/10.1002/jmv.25738
Lu H, Stratton CW, Tang YW. The Wuhan SARS-CoV-2-What's Next for China. J Med Virol. 2020;92(6):546-547. PubMed PMID: 32115732.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Wuhan SARS-CoV-2-What's next for China. AU - Lu,Hongzhou, AU - Stratton,Charles W, AU - Tang,Yi-Wei, Y1 - 2020/03/18/ PY - 2020/02/13/received PY - 2020/02/26/accepted PY - 2020/3/3/pubmed PY - 2020/7/1/medline PY - 2020/3/3/entrez SP - 546 EP - 547 JF - Journal of medical virology JO - J Med Virol VL - 92 IS - 6 SN - 1096-9071 UR - https://www.unboundmedicine.com/medline/citation/32115732/The_Wuhan_SARS_CoV_2_What's_next_for_China_ L2 - https://doi.org/10.1002/jmv.25738 DB - PRIME DP - Unbound Medicine ER -